neuraxis.com (NRXS) - Uzoq muddatli majburiyatlarning kapitalga nisbati

NeurAxis, Inc. - NRXS emitenti grafik logotipi

NeurAxis, Inc. (NRXS) biznesi tibbiyotning gumanitar maqomi bilan himoyalangan bo'lib, bu tashqi siyosiy risklarni minimallashtiradi. Uzoq muddatli qarzning kapitalga nisbati dinamikasi moliyaviy avtonomiyaning joriy vektorini namoyish etadi, bunda 0.02 ushbu metrikaning so'nggi darajasini ifodalaydi. Sarflanadigan materiallar uchun takrorlanuvchi savdo modeli barqaror marjani ta'minlaydi, neyrostimulyatsiyaning defensiv tabiati esa iqtisodiy sikllardan qat'i nazar, barqaror talabni kafolatlaydi.

NeurAxis Inc. (NRXS): Uzoq muddatli qarzning o'z kapitaliga nisbati 21.02.2024dan 29.10.2026gacha

NeurAxis, Inc. kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi NeurAxis Inc.|NRXS - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati NeurAxis, Inc.|NRXS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati NeurAxis|NRXS - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati neuraxis.com|NRXS - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati NeurAxis, Inc.|NRXS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi neuraxis.com|NRXS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar NeurAxis, Inc.|NRXS - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari NeurAxis|Oraliq qoplash koeffitsiyenti neuraxis.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
NRXS - Sof foyda
Kompaniyaning jamlanma tahlili:NRXS (NeurAxis Inc.)
NeurAxis Inc. original mahsuloti

Ushbu koeffitsient uzoq muddatli majburiyatlarning kapitalga nisbati sifatida hisoblanadi va qarz moliyalashtirishning umumiy aktivlar qiymatiga ta'sirini aks ettiradi. Mazkur ko'rsatkich kompaniyaning muddati bir yildan ortiq bo'lgan kreditorlarga bo'lgan bog'liqlik darajasini o'lchaydi. NeurAxis, Inc. (NRXS) uchun ishlab chiqarish va klinik sinovlarni autsorsing qilishda bunday kapital tuzilmasi hal qiluvchi ahamiyatga ega. Uzoq muddatli kredit leverajini tahlil qilish biznes modelining foiz stavkalari oshishiga nisbatan barqarorligini baholash imkonini beradi.

Raqobatdosh kompaniyalar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi HRMY (harmonybiosciences.com)|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Trevi Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Praxis Corp PRAX|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CBLL (ceribell.com)|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Alector (ALEC) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMER (Omeros Corp.)|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzdorlikning kapitalga nisbati acimmune.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc. VYGR|Uzoq muddatli qarzdorlikning kapitalga nisbati Neumora (NMRA)|SCLX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG: Uzoq muddatli qarzning kapitalga nisbati|CGTX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi SAVA (Cassava Sciences Inc)|Uzoq muddatli qarzning kapitalga nisbati ASRT|Uzoq muddatli qarzning o'z kapitaliga nisbati coyatherapeutics.com COYA|Vistagen - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Ovid Therapeutics Inc (OVID)|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|CRVO (CervoMed, Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|alteritytherapeutics.com (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Clene - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati PEPG|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi JUNS (jupiterneurosciences.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Relmada Therapeutics, Inc. (RLMD)|Uzoq muddatli qarzdorlikning kapitalga nisbati Annovis Bio Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Grace Therapeutics GRCE|AIFF: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NeuroSense Therapeutics|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MetaVia (MTVA) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|PASG: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|NERV - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|ADXN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cyclerion Therapeutics|PTIX (protagenic.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pasithea Therapeutics Corp. (KTTA) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|ATXI: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati BCLI|Uzoq muddatli qarzning kapitalga nisbati Cara Therapeutics Inc (CARA)|Chromocell Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|ELYM: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Longboard Pharmaceuticals Inc LBPH|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGN - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|SAGE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzdorlikning kapitalga nisbati Trevena Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|WENA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati